Mystery AI Model Revealed 🧠 Cancer Drug Beats AstraZeneca 💊 Earth-Moon Laser Breakthrough 🌕

2026-08-31 | subscribe | homepage

Welcome back to China Insights Weekly. Here are some of the key highlights for this week’s edition:

• HarmonyOS passes 100,000 native apps, as Huawei pushes for a larger global role

• Robot shipments jump nearly 300%, with Chinese vendors taking all top five spots

• EV charging power use rises 50.3%, driving China’s record electricity demand

• Taobao selects 17 premium brands, with its first showcase generating RMB 100 million

Remember to follow us on LinkedIn, X or Facebook.

🚀 Headlines

Mystery AI model revealed as Zhipu’s GLM-5.3-Flash after topping OpenRouter (link)

Z.AI, the Beijing lab behind the GLM series, released Ox Alpha as an open-weight model named GLM-5.3-Flash on August 26, under an MIT licence. The model features 320 billion total parameters with 18 billion active per token, a 1,048,576-token context window, and accepts text, image, and video input. During its anonymous week, it processed 100 trillion tokens daily, running entirely on roughly 100,000 domestic Chinese AI chips, marking the first time Chinese silicon has carried frontier-scale global traffic. The stealth launch, capturing massive developer traffic before revealing its identity, represents a new competitive tactic that allows Chinese labs to test at scale without reputation risk.

Akeso’s Chinese cancer drug beat AstraZeneca head-to-head (link)

Akeso's ivonescimab beat AstraZeneca's Imfinzi in a Phase III trial for advanced biliary tract cancer, a disease with a five-year survival rate below 5%. The 682-patient study marks the drug's fifth Phase III win after four in lung cancer. In September 2024, ivonescimab stunned oncology circles by beating Merck's Keytruda in a head-to-head lung cancer trial, cutting the risk of disease progression or death by nearly half. Imfinzi generated over USD 6 billion in revenue last year, up 28%. The drug is already licensed to Summit Therapeutics, which is seeking US approval. While biliary tract cancer is rare, the result opens the door to a broader range of solid tumours.

China bets on green hydrogen as the future of energy (link)

China has tripled its operational green hydrogen capacity since the end of 2024, reaching nearly 250,000 tons annually, over twice the rest of the world combined. Beijing's latest five-year plan targets an eightfold increase to 2 million tons annually by 2030. The strategy leverages two structural advantages: a vast industrial base resistant to decarbonisation and a growing surplus of renewable energy, so abundant that increasing amounts are being wasted. Diverting excess wind and solar to green hydrogen both solves the utilisation problem and, when converted to chemicals like ammonia, enables long-duration energy storage akin to a liquid battery. Following the playbook that built its EV dominance, Beijing is building supply first, betting demand will follow.

Huawei’s HarmonyOS surpasses 100,000 apps and aims for 2nd globally (link)

Huawei's HarmonyOS has been formally recognised as the world's third-largest mobile operating system. At the HarmonyOS Ecosystem Conference, the company revealed that native apps had surpassed 100,000, with over 400,000 total applications available. Devices running HarmonyOS 6 exceeded 80 million shipments by August 20, and the ecosystem is on track to cross 100 million users in the fourth quarter. Beyond mobile, OpenHarmony devices have surpassed 1.35 billion cumulative units across automobiles, home appliances and metallurgy. Huawei now aims to make HarmonyOS a global "second choice".

China’s AI chipmakers are turning self-reliance into sales (link)

China's top three GPU makers, Cambricon, Hygon and Moore Threads, turned US export curbs into commercial momentum in the first half of 2026, posting results that put each on a path to sustained profitability. Cambricon led the pack: revenue and net profit both more than doubled year-on-year, to 6 billion yuan (USD 892m) and 2.3 billion yuan, respectively, marking its first back-to-back quarterly net profits above 1 billion yuan. Nearly all of its revenue came from supplying cloud-based AI chips to major large-model developers like DeepSeek and Moonshot AI. Hygon booked the largest top line, 9.1 billion yuan in revenue, up 66.5%, with net profit of 1.8 billion yuan. Moore Threads led in growth, with revenue surging 147.4% to 1.7 billion yuan, narrowing its net loss to just 11.6 million yuan. IDC projects China's acceleration server market will expand from USD 37.7 billion in 2025 to USD 150.1 billion by 2030.